Kun Run Biotechnology, Inc. KURU Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Kun Run Biotechnology, Inc. KURU Company Overview 

Stock Message Board http://investorshangout.com/search?q=KURU&...mp;yt1=Go!

Kun Run Biotechnology, Inc. KURU Current Price and Quotes
Last Price 0.20
Previous Close 0.20 Open N/A
Daily Range N/A - N/A 52wk Range 0.20 - 0.20
Volume 0 Dividend N/A
Average Vol (3m) 3,802 Yield N/A
Kun Run Biotechnology, Inc. KURU
Company Information

168 Nanhai Avenue
Haikou City
Hainan Province 570216
China

Phone: 86-898-6680-2207

Kun Run Biotechnology, Inc. KURU
Kun Run Biotechnology, Inc. KURU
Financial Reportings and Disclosures

Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Dec 10, 2010
Audited Financials Not Available
Latest Report Sep 30, 2010 10-Q
CIK 0001393526
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2006
Employees Not Available
Company Officers/Contacts

Xiaoqun Ye CEO
Company Directors

Not Available
Company Notes

Formerly=Aspen Racing Stables, Inc. until 11-2008
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Kun Run Biotechnology, Inc. KURU
KURU Security Details

Share Structure

Market Value1 $5,000,000 a/o Sep 06, 2013
Shares Outstanding 25,000,000 a/o Mar 30, 2009
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 13 a/o Apr 03, 2009
Security Notes

Capital Change=shs decreased by 1 for 3.42857 split. Pay date=09/08/2008.
Short Selling Data

Short Interest 0 (-100%)
Sep 15, 2009
Significant Failures to Deliver  No
Transfer Agent(s)

Securities Transfer Corp

Kun Run Biotechnology, Inc. KURU Recent News

Kun Run Biotechnology, Inc. KURU Financials
KURU


KURU Kun Run Biotechnology, Inc. Research DD Guide

KURU Kun Run Biotechnology, Inc. Stock Message Board http://investorshangout.com/search?q=KURU&...mp;yt0=Go!
KURU Kun Run Biotechnology, Inc. Stock Quote http://www.otcmarkets.com/stock/KURU/quote
KURU Kun Run Biotechnology, Inc. Stock Chart http://www.otcmarkets.com/stock/KURU/chart
KURU Kun Run Biotechnology, Inc. Company Info http://www.otcmarkets.com/stock/KURU/company-info
KURU Kun Run Biotechnology, Inc. Recent News http://www.otcmarkets.com/stock/KURU/news
KURU Kun Run Biotechnology, Inc. Financials http://www.otcmarkets.com/stock/KURU/financials
KURU Kun Run Biotechnology, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/KURU/filings
KURU Kun Run Biotechnology, Inc. Short Sales http://www.otcmarkets.com/stock/KURU/short-sales
KURU Kun Run Biotechnology, Inc. Insider Disclosure http://www.otcmarkets.com/stock/KURU/insider-transactions
KURU Kun Run Biotechnology, Inc. Research Reports http://www.otcmarkets.com/stock/KURU/research
KURU Kun Run Biotechnology, Inc. Summary http://finance.yahoo.com/q?s=KURU
KURU Kun Run Biotechnology, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=KURU+Historical+Prices
KURU Kun Run Biotechnology, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=KURU
KURU Kun Run Biotechnology, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=KURU+Basic+Chart
KURU Kun Run Biotechnology, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=KURU+Basic+Tech.+Analysis
KURU Kun Run Biotechnology, Inc. Headlines http://finance.yahoo.com/q/h?s=KURU+Headlines
KURU Kun Run Biotechnology, Inc. Press Releases http://finance.yahoo.com/q/p?s=KURU+Press+Releases
KURU Kun Run Biotechnology, Inc. Company Profile http://finance.yahoo.com/q/pr?s=KURU+Profile
KURU Kun Run Biotechnology, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=KURU+Key+Statistics
KURU Kun Run Biotechnology, Inc. Industry http://finance.yahoo.com/q/in?s=KURU+Industry
KURU Kun Run Biotechnology, Inc. Major Holders http://finance.yahoo.com/q/mh?s=KURU+Major+Holders
KURU Kun Run Biotechnology, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=KURU+Insider+Transactions
KURU Kun Run Biotechnology, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=KURU+Insider+Roster
KURU Kun Run Biotechnology, Inc. Income Statement http://finance.yahoo.com/q/is?s=KURU
KURU Kun Run Biotechnology, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=KURU
KURU Kun Run Biotechnology, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=KURU+Cash+Flow&annual
KURU Kun Run Biotechnology, Inc. Nasdaq http://www.nasdaq.com/symbol/KURU
KURU Kun Run Biotechnology, Inc. Market Watch http://www.marketwatch.com/investing/stock/KURU
KURU Kun Run Biotechnology, Inc. Bloomberg http://www.bloomberg.com/quote/KURU:US
KURU Kun Run Biotechnology, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=KURU
KURU Kun Run Biotechnology, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=KURU
KURU Kun Run Biotechnology, Inc. Barchart http://www.barchart.com/quotes/stocks/KURU
KURU Kun Run Biotechnology, Inc. OTC Short Report http://otcshortreport.com/index.php?index=KURU
KURU Kun Run Biotechnology, Inc. Investopedia http://www.investopedia.com/markets/stocks/KURU/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 21

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 14

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 5

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
New JPA Aims to Energize Inland Empire's Water Supply

Updated Category News Views 25

Fresh Steps in San Bernardino's Infrastructure Strategy Here's a twist for you: public agencies in San Bernardino County decided enough with the same old, same old and cooked up a new joint powers authority (JPA). They call it the San Bernardino Water and Power Authority, which sounds snappy enough for a meeting room nameplate, I reckon. Who's Steering the Ship? Leading...

Continue Reading
BETR's Legal Clash: Investor Action Deadline Nears

Updated Category News Views 5

BETR's Woes in the Legal Spotlight Investors who’ve been keeping an eye on Better Home & Finance Holding Company—trading as BETR on NASDAQ—might wanna pinch themselves. Not every day do you see a class action lawsuit waiting on the horizon like this one. The folks over at Schall, Brown & Schwartz LLP, those wily veterans in shareholder rights litigation, are...

Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations

Updated Category News Views 7

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Continue Reading
Understanding Truck Accident Settlements in Memphis

Updated Category News Views 9

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

Continue Reading
Artificial Stone Silicosis: A Silent Threat Unveiled

Updated Category News Views 5

The Harsh Reality Behind Artificial Stone You're slicing into your steak at a fancy dinner, and for a moment, you marvel at the countertop beneath your dish—a smooth, sleek surface that's likely made of artificial stone. But beneath that lustrous facade lurks a silent killer affecting those fabricating these countertops every day. Voices from the Frontline Recently,...

Continue Reading
Nest Health Appoints Peter Morrison for Multistate Expansion

Updated Category News Views 11

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 18

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading

Top 5 Most Recently Viewed Articles

Introducing IZZY: The AI Assistant in Influencer Marketing

Updated Category News Views 276

IZEA Introduces IZZY: The AI Assistant for Influencer Marketing IZEA Worldwide, Inc. (NASDAQ: IZEA), a frontrunner in technology, data, and services for the Creator Economy, has unveiled IZZY, a groundbreaking AI assistant tailored for influencer marketing professionals. This powerful tool is now accessible to users of IZEA Flex, IZEA's all-encompassing influencer...

Continue Reading
Empowering Women's Health: Doina Dragusanu's New Initiative

Updated Category News Views 83

Transformative Wellness Program for Women Facing Menopause Holistic, evidence-based support is now available for women aged 40–65 to manage menopause symptoms and reclaim wellness. With over a billion women globally predicted to face menopause in the coming years, Doina-Mihaela Dragusanu, a nurse and certified menopause coach, has developed a six-month program aimed...

Continue Reading
Marine Petroleum Trust Declares Higher Quarterly Distribution

Updated Category News Views 84

Marine Petroleum Trust's Latest Cash Distribution Announcement Marine Petroleum Trust (NASDAQ: MARPS) has announced the declaration of a quarterly cash distribution to its unit holders. This distribution stands at $0.102923 per unit, marking a notable increase when compared to the previous quarter's distribution of $0.094886 per unit. The payment is scheduled for December...

Continue Reading
Exciting Growth Forecast for Forklift Trucks Market Through 2028

Updated Category News Views 91

Exciting Growth Forecast for Forklift Trucks Market Through 2028 The global forklift trucks market is on the brink of significant expansion, anticipating a remarkable growth of approximately USD 23.26 billion from 2024 to 2028. In analyzing this sector, experts project a compound annual growth rate (CAGR) of around 7.2% throughout the forecast period. The driving force...

Continue Reading
Clarity Pharmaceuticals Celebrates Milestone in Prostate Cancer Research

Updated Category News Views 92

Clarity Pharmaceuticals Marks a Significant Achievement in Urology Clarity Pharmaceuticals (ASX: CU6), a pioneering clinical-stage radiopharmaceutical company, has received notable recognition for its groundbreaking research into prostate cancer through an abstract acceptance for oral presentation at the upcoming European Association of Urology (EAU) Congress 2026. This...

Continue Reading